Olmesartan Medoxomil/Amlodipine/Hct Teva (Olmesartan Medoxomil, Hydrochlorothiazide, Amlodipine Besilate)

Olmesartan Medoxomil/Amlodipine/Hct Teva is prescribed for hypertension and related cardiovascular conditions.

• Hypertension: helps lower systolic and diastolic blood pressure to reduce cardiovascular risk.
• Chronic heart failure: used as part of combination therapy to improve cardiac output and symptom control.
• Diabetic nephropathy: assists in slowing progression of kidney damage by controlling blood pressure.
• Stroke prevention: contributes to secondary prevention by maintaining target blood pressure levels.
• Peripheral arterial disease: aids in improving blood flow and reducing limb ischemia symptoms.

• The combination product blocks the angiotensin II type 1 receptor (Olmesartan), relaxes vascular smooth muscle via calcium‑channel inhibition (Amlodipine), and promotes natriuresis through inhibition of renal sodium reabsorption (Hydrochlorothiazide). Together these actions reduce systemic vascular resistance, lower blood volume, and decrease cardiac afterload, resulting in sustained blood‑pressure reduction.

Side effects may vary in frequency and severity.

Common Side Effects

• Headache
• Peripheral edema
• Dizziness
• Flushing
• Fatigue
• Cough

Serious or Rare Side Effects

• Angio‑edema
• Severe hypotension
• Electrolyte imbalance (e.g., hyponatremia, hyperkalemia)
• Acute kidney injury
• Liver function abnormalities
• Pancreatitis

When using this combination antihypertensive, several safety considerations apply.

• Renal function monitoring: assess baseline creatinine and eGFR, especially in patients with chronic kidney disease.
• Electrolyte balance: check serum potassium and sodium periodically.
• Pregnancy contraindication: avoid use during pregnancy due to fetal toxicity.
• Concomitant diuretics: monitor for excessive diuresis and orthostatic hypotension.
• Elderly patients: start at lower doses and titrate cautiously.
• Store at ambient temperature: keep in original packaging, protect from light and moisture.

Olmesartan Medoxil ​​  ​   ​  ​  ​  ​  ​  ​   ​  ​  

Major Interactions (Avoid)

• Concomitant use with ACE‑Inhibitors    

t   t  t  t  t  t  t  Moderate   t  t  t  t  t  t  t  t  -   t  t  t t